Traceable evidence
Findings remain connected to source perspectives and relevant supporting evidence.
Intelligence Deliverables
Evidence-led intelligence.
Built for decisions.
Grapon turns targeted expert perspectives and competitive evidence into clear intelligence that helps pharma and biotech teams understand what is changing, why it matters and where the strategic implications lie.
Source-backed.
Decision-focused.
Decision-focused.
The Work Behind The Insight
Every conclusion has an evidence trail.
Interview outputs preserve the source perspective and its context. Strategic assessments bring those perspectives together with relevant clinical, commercial and regulatory evidence—distinguishing what a source said from what the combined evidence may mean for the asset or market.
01 · Primary Research
Expert perspectives, captured at source level.
Interview transcripts retain the substance of the discussion, role-level source context and the connection to the intelligence question. Direct perspectives remain distinguishable from analyst interpretation, allowing clients to revisit the evidence behind an assessment.
02 · Strategic Synthesis
Source evidence translated into competitive implications.
Grapon synthesis connects what experts are observing with the evidence and competitive context. The resulting assessment identifies what supports a position, what remains unresolved and which developments could change the outlook—so teams can focus attention on the decisions that matter.
What clients receive
Clear interpretation
Source statements are separated from synthesis, with implications explained in context.
Decision relevance
Assessments highlight the developments, uncertainties and competitive questions that warrant attention.
Discuss an intelligence requirement.
Bring us the question your team needs to answer. We can shape the research and deliverable around the decision.